PTGER4 and breast cancer: As expected, an EP4 agonist (ONO-AE1-437) promptly increased the Ca2+ concentrations in OSCC cells (HSC-3 cells), GBM cells (LN229 cells) and human breast cancer cells (MCF7 cells).